Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1335-1339

  Vordermark, Dirk ^a   Lackenbauer, Andrea ^a   Wulf, Jörn ^a,b   Guckenberger, Matthias ^a   Flentje, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Lindenhofspital   (Switzerland)

Author keywords

Breast cancer; Breast conserving therapy; Margin; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AXILLA; BREAST TUMOR; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 38449086599     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1335     Document Type: Article

References (18)

1. Singletary SE: Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184: 383-393, 2002.
2. Pomp J, Blom J, Zwinderman AH, Sastrowijoto SH and van Krimpen C: Analysis of local recurrence after breast conservative treatment for invasive breast cancer: a single institution cohort. Oncol Rep 14: 1255-1261, 2005.
3. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347: 1233-1241, 2002. (Pubitemid 35176242)
4. Jacobson J, Danforth D, Cowan K, D'Angelo T, Steinberg S, Pierce L, Lippmann ME, Lichter AS, Glatstein E and Okunieff P: Ten-year results of the National Cancer Institute's randomized trial of breast conservation versus mastectomy for stage I and II breast cancer. N Engl J Med 332: 907-911, 1995.
5. Van Dongen J, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K and Bartelink H: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92: 1143-1150, 2000.
6. Arriagada R, Le MG, Rochard F and Contesso G: Conservative treatment versus mastectomy in early breast cancer: patterns of failure with fifteen years of follow-up. J Clin Oncol 14: 1558-1564, 1996. (Pubitemid 26134214)
7. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccorizzi R, Luini A, Aguilar M and Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227-1232, 2002. (Pubitemid 35176241)
8. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E and Powell S: Current perceptions regarding surgical margin status after breast-conserving therapy. Results of a survery. Ann Surg 241: 629-639, 2005. (Pubitemid 40397311)
9. Kreienberg R, Kopp I, Lorenz W, Budach W, Dunst J, Lebeau A, Lück H-J, v. Minckwitz G, Possinger K, Sauerbrei W, Sauerland S, Souchon R, Thomssen C, Untch M, Volm T, Weis J, Schmitt-Reisser B, Koller M, Heilmann V: Diagnostik, Therapie und Nachsorge des Mammakarzinoms der Frau. Eine nationale S3-Leitlinie. Deutsche Krebsgesellschaft (ed): ISTO, Frankfurt, 2004.
10. Bartelink H, Horiot JC, Poortmans P, Struikmans H, van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L and Pierart M: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Eng J Med 345: 1378-1387, 2001.
11. Neuschatz AC, Di Petrillo T, Safaii H, Lyn Price L, Schmitt-Ullrich RK and Wazer DE: Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 97: 30-39, 2003. (Pubitemid 36033860)
12. Smitt MC, Nowels K, Carlson RW and Jeffrey SS: Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 57: 979-985, 2003. (Pubitemid 37324115)
13. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Oei SB, Peterse HL, Pierart M, Poortmans PM, Struikmans H, van den Bogaert W and Bartelink H: Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39: 932-944, 2003. (Pubitemid 36428625)
14. Van't Veer L, Dai H, van der Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002. (Pubitemid 34130608)
15. Varangot M, Barrios E, Sonora C, Aizen B, Pressa C, Estrugo R, Lavigna R, Muse I, Osinaga E and Berois N: Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer. Oncol Rep 14: 537-545, 2005.
16. Zhu L, Loo WT, Cheng CW and Chow LW: Possible predictive markers related to micro-metastasis in breast cancer patients. Oncol Rep 15: 1217-1223, 2006.
17. Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY and van de Vijver MJ: Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8: R62, 2006.
18. Bartelink H, Boersma LJ, Leer JW and Poortmans P: Radiation dose intensity study in breast cancer in young women: a randomized phase III trial of additional dose to the tumor bed. Netherlands Cancer Institute, Amsterdam, 2004 (ClinicalTrials.gov identifier NCT00212121).